Oncology News and Research

RSS
Researchers design antibody that recognizes and destroys blood cancer stem cells

Researchers design antibody that recognizes and destroys blood cancer stem cells

Study suggests best sequence of therapies for brain metastases in EGFR mutant lung cancer patients

Study suggests best sequence of therapies for brain metastases in EGFR mutant lung cancer patients

BRCA1 gene required for survival of blood forming stem cells, UT Southwestern study finds

BRCA1 gene required for survival of blood forming stem cells, UT Southwestern study finds

Scientists discover new way to inhibit growth of glioblastoma

Scientists discover new way to inhibit growth of glioblastoma

Scientists discover cause of tumour resistance to angiogenesis inhibitors

Scientists discover cause of tumour resistance to angiogenesis inhibitors

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

Cervical cancer mortality rates higher than previously thought, study reveals

Cervical cancer mortality rates higher than previously thought, study reveals

EMQ to showcase healthcare and life sciences project at Arab Health

EMQ to showcase healthcare and life sciences project at Arab Health

Precision medicine advances diagnosis and treatment of children with brain tumors

Precision medicine advances diagnosis and treatment of children with brain tumors

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

MGH-developed CTC-iChip with digital PCR assay improves detection of early-stage liver cancer

New study estimates overall prevalence of genital HPV infection among men in the U.S.

New study estimates overall prevalence of genital HPV infection among men in the U.S.

Northwestern Medicine investigators to lead clinical trial for people with rare cancers

Northwestern Medicine investigators to lead clinical trial for people with rare cancers

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

‘Collateral lethality’ may create new therapeutic options for several cancers

‘Collateral lethality’ may create new therapeutic options for several cancers

Researcher awarded $1.8 million grant to explore how chronic stress impacts cancer development

Researcher awarded $1.8 million grant to explore how chronic stress impacts cancer development

Biosimilars create chances to improve sustainability and affordability of cancer treatment

Biosimilars create chances to improve sustainability and affordability of cancer treatment

UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

Research findings could offer ways of fighting treatment resistance in oesophageal cancer

Research findings could offer ways of fighting treatment resistance in oesophageal cancer

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.